Back
Regeneron Pharmaceuticals Vs. Manhattan Associates Industry Stock Comparison
Buy
71
REGN
Regeneron Pharmaceuticals
Last Price:
957.67
Seasonality Move:
11.17%
Sell
49
MANH
Manhattan Associates
Last Price:
210.80
Seasonality Move:
6.34%
Buy
71
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $957.00. The Score for REGN is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Manhattan Associates (MANH)
is a Sell
Is Manhattan Associates a Buy, Sell or Hold?
- The current Manhattan Associates [MANH] share price is $210.76. The Score for MANH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- MANH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $957.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
MANH Stock Price Chart
What is Manhattan Associates's stock price today?
-
The Manhattan Associates share price today is $210.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MANH is experiencing slight buying pressure.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.92 | Sell |
| Relative Strength Index (14 RSI): | 64.09 | Buy |
| Chaikin Money Flow: | 487782 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (892.75 - 943.19) | Buy |
| Bollinger Bands (100): | (891.52 - 968.26) | Buy |
MANH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.55 | Sell |
| Relative Strength Index (14 RSI): | 31.82 | Sell |
| Chaikin Money Flow: | 48155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (213.33 - 241.89) | Sell |
| Bollinger Bands (100): | (215.35 - 250.31) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 907.64 | Buy |
| 20-day SMA: | 909.78 | Buy |
| 50-day SMA: | 944.13 | Buy |
| 200-day SMA: | 868.84 | Buy |
| 8-day EMA: | 917.46 | Buy |
| 20-day EMA: | 916.72 | Buy |
| 50-day EMA: | 927.39 | Buy |
| 200-day EMA: | 877.93 | Buy |
MANH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.37 | Buy |
| 20-day SMA: | 223.63 | Sell |
| 50-day SMA: | 239.96 | Sell |
| 200-day SMA: | 217.28 | Sell |
| 8-day EMA: | 211.81 | Sell |
| 20-day EMA: | 221.25 | Sell |
| 50-day EMA: | 231.14 | Sell |
| 200-day EMA: | 216.88 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, a decrease next quarter of $0.35 per share, an increase this year of $1.87 per share, and an increase next year of $3.04 per share.
Manhattan Associates Earnings Growth & MANH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.51 per share.
Regeneron Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Manhattan Associates Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||